We provide 1 form of Avacopan
Avacopan
1346623-17-3
|
581.267
|
8.191
Avacopan is an orally bioavailable complement 5a receptor (C5aR) antagonist for the treatment of severe anti-neutrophil cytoplasmic (auto)antibody (ANCA)-associated vasculitis.
avacopan
Avacopan is an orally bioavailable complement 5a receptor (C5aR) antagonist for the treatment of severe anti-neutrophil cytoplasmic (auto)antibody (ANCA)-associated vasculitis.
avacopan
$71/5 mg
(EBC)
1
We provide 0 compound for Avacopan